Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. more
Time Frame | HOLX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.06% | -1.95% | 0.69% |
1-Month Return | -4.53% | -3.36% | 1.53% |
3-Month Return | -8.34% | -6.93% | 11.27% |
6-Month Return | 2.46% | -1.83% | 13.49% |
1-Year Return | 10.35% | 8.53% | 31.62% |
3-Year Return | 0.8% | 7.58% | 30.33% |
5-Year Return | 45.47% | 44.7% | 93.83% |
10-Year Return | 180.96% | 103.96% | 195.13% |
Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 3.78B | 5.63B | 4.86B | 4.03B | 4.03B | [{"date":"2020-09-30","value":67.05,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":86.34,"profit":true},{"date":"2023-09-30","value":71.56,"profit":true},{"date":"2024-09-30","value":71.56,"profit":true}] |
Cost of Revenue | 1.55B | 1.84B | 1.87B | 1.96B | 1.80B | [{"date":"2020-09-30","value":79.07,"profit":true},{"date":"2021-09-30","value":93.75,"profit":true},{"date":"2022-09-30","value":95.23,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":92.02,"profit":true}] |
Gross Profit | 2.23B | 3.80B | 3.00B | 2.07B | 2.23B | [{"date":"2020-09-30","value":58.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":78.97,"profit":true},{"date":"2023-09-30","value":54.57,"profit":true},{"date":"2024-09-30","value":58.69,"profit":true}] |
Gross Margin | 58.98% | 67.39% | 61.64% | 51.40% | 55.28% | [{"date":"2020-09-30","value":87.52,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":91.46,"profit":true},{"date":"2023-09-30","value":76.26,"profit":true},{"date":"2024-09-30","value":82.02,"profit":true}] |
Operating Expenses | 1.10B | 1.31B | 1.37B | 1.31B | 1.35B | [{"date":"2020-09-30","value":80.7,"profit":true},{"date":"2021-09-30","value":96.07,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":95.86,"profit":true},{"date":"2024-09-30","value":98.43,"profit":true}] |
Operating Income | 1.10B | 2.48B | 1.64B | 668.40M | 882.60M | [{"date":"2020-09-30","value":44.55,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":66.13,"profit":true},{"date":"2023-09-30","value":26.95,"profit":true},{"date":"2024-09-30","value":35.58,"profit":true}] |
Total Non-Operating Income/Expense | (215.30M) | (211.40M) | (134.20M) | 17.10M | - | [{"date":"2020-09-30","value":-1259.06,"profit":false},{"date":"2021-09-30","value":-1236.26,"profit":false},{"date":"2022-09-30","value":-784.8,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Pre-Tax Income | 1.00B | 2.36B | 1.59B | 676.10M | 865.10M | [{"date":"2020-09-30","value":42.43,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":67.27,"profit":true},{"date":"2023-09-30","value":28.63,"profit":true},{"date":"2024-09-30","value":36.64,"profit":true}] |
Income Taxes | (108.60M) | 491.40M | 286.20M | 220.10M | 75.60M | [{"date":"2020-09-30","value":-22.1,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":58.24,"profit":true},{"date":"2023-09-30","value":44.79,"profit":true},{"date":"2024-09-30","value":15.38,"profit":true}] |
Income After Taxes | 1.11B | 1.87B | 1.30B | 456.00M | - | [{"date":"2020-09-30","value":59.39,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":69.64,"profit":true},{"date":"2023-09-30","value":24.39,"profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Income From Continuous Operations | 1.11B | 1.87B | 1.30B | 456.00M | - | [{"date":"2020-09-30","value":59.39,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":69.64,"profit":true},{"date":"2023-09-30","value":24.39,"profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Net Income | 1.12B | 1.87B | 1.30B | 456.00M | 789.50M | [{"date":"2020-09-30","value":59.59,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":69.57,"profit":true},{"date":"2023-09-30","value":24.37,"profit":true},{"date":"2024-09-30","value":42.19,"profit":true}] |
EPS (Diluted) | 4.00 | 8.39 | 6.01 | 3.95 | 4.08 | [{"date":"2020-09-30","value":47.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":71.63,"profit":true},{"date":"2023-09-30","value":47.08,"profit":true},{"date":"2024-09-30","value":48.63,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
HOLX | |
---|---|
Cash Ratio | 2.25 |
Current Ratio | 3.69 |
Quick Ratio | 3.03 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
HOLX | |
---|---|
ROA (LTM) | 6.45% |
ROE (LTM) | 13.85% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
HOLX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.44 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.56 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
HOLX | |
---|---|
Trailing PE | 22.83 |
Forward PE | 17.67 |
P/S (TTM) | 4.31 |
P/B | 3.33 |
Price/FCF | 51 |
EV/R | 4.32 |
EV/Ebitda | 13.44 |
PEG | 1.21 |
Hologic Inc (HOLX) share price today is $75.79
Yes, Indians can buy shares of Hologic Inc (HOLX) on Vested. To buy Hologic Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HOLX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Hologic Inc (HOLX) via the Vested app. You can start investing in Hologic Inc (HOLX) with a minimum investment of $1.
You can invest in shares of Hologic Inc (HOLX) via Vested in three simple steps:
The 52-week high price of Hologic Inc (HOLX) is $84.67. The 52-week low price of Hologic Inc (HOLX) is $68.15.
The price-to-earnings (P/E) ratio of Hologic Inc (HOLX) is 22.6928
The price-to-book (P/B) ratio of Hologic Inc (HOLX) is 3.33
The dividend yield of Hologic Inc (HOLX) is 0.00%
The market capitalization of Hologic Inc (HOLX) is $17.10B
The stock symbol (or ticker) of Hologic Inc is HOLX